Similar articles

• Dementia.

  Warner J, Butler R, Jackson E. Warner J, et al. Clin Evid. 2002 Dec;(8):927-50. Clin Evid. 2002. Update in: Clin Evid. 2003 Jun;(9):1010-33. PMID: 12603921 Updated. Review. No abstract available.
• [Challenging pharmacotherapy in dementia].

  Ihl R. Ihl R. MMW Fortschr Med. 2009 Mar 26;151(13):46-8. MMW Fortschr Med. 2009. PMID: 19504818 German. No abstract available.
• Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art.

  Fariello RG. Fariello RG. Funct Neurol. 1997 May-Aug;12(3-4):221-5. Funct Neurol. 1997. PMID: 9218984 Review. No abstract available.
• [Reality of pharmacotherapy in nursing home patients with dementia. Results of a new field study of 23 nursing homes].

  Hallauer J. Hallauer J. Krankenpfl J. 2005;43(7-10):206. Krankenpfl J. 2005. PMID: 16515277 German. No abstract available.
• Outcomes for clinical trials in mild-to-moderate dementia to evaluate drugs with presumably symptomatic effects.

  Frolich L. Frolich L. J Nutr Health Aging. 2007 Jul-Aug;11(4):357-8. J Nutr Health Aging. 2007. PMID: 17653499 Review. No abstract available.